Progyny, Inc. Working Capital

Working Capital of PGNY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Working Capital growth rates and interactive chart. Working capital, also known as net working capital (NWC), is the difference between a company’s current assets, such as cash, accounts receivable (customers’ unpaid bills) and inventories of raw materials and finished goods, and its current liabilities, such as accounts payable. Net operating working capital is a measure of a company's liquidity and refers to the difference between operating current assets and operating current liabilities. In many cases these calculations are the same and are derived from company cash plus accounts receivable plus inventories, less accounts payable and less accrued expenses. Working capital is a measure of a company's liquidity, operational efficiency and its short-term financial health. If a company has substantial positive working capital, then it should have the potential to invest and grow. If a company's current assets do not exceed its current liabilities, then it may have trouble growing or paying back creditors, or even go bankrupt.

Highlights and Quick Summary

  • Working Capital for the quarter ending September 29, 2021 was $150 Million (a 7.33% increase compared to previous quarter)
  • Year-over-year quarterly Working Capital increased by 33.36%
  • Annual Working Capital for 2020 was $112 Million (a 16.78% increase from previous year)
  • Annual Working Capital for 2019 was $96.3 Million (a -1799.58% decrease from previous year)
  • Annual Working Capital for 2018 was $-5.67 Million (a 466.5% increase from previous year)
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Working Capital of Progyny, Inc.

Most recent Working Capitalof PGNY including historical data for past 10 years.

Interactive Chart of Working Capital of Progyny, Inc.

Progyny, Inc. Working Capital for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $149.94 $139.71 $126.8
2020 $112.44 $110.42 $102.04 $102.88 $112.44
2019 $96.28 $-4.23 $-0.55 $96.28
2018 $-5.67 $-5.67
2017 $-1.0 $-1.0

Business Profile of Progyny, Inc.

Sector: Healthcare
Industry: Health Information Services
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.